Hider RC - Search Results

1

Protoporphyria induced by the orally active iron chelator 1,2-diethyl-3-hydroxypyridin-4-one in C57BL/10ScSn mice.

Smith AG, Clothier B, Francis JE, Gibbs AH, De Matteis F, Hider RC. Smith AG, et al. Among authors: hider rc. Blood. 1997 Feb 1;89(3):1045-51. Blood. 1997. PMID: 9028337 Free article.

2

Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94.

Carthew P, Smith AG, Hider RC, Dorman B, Edwards RE, Francis JE. Carthew P, et al. Among authors: hider rc. Biometals. 1994 Oct;7(4):267-71. doi: 10.1007/BF00144120. Biometals. 1994. PMID: 7812111

3

Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.

Vlachodimitropoulou E, Chen YL, Garbowski M, Koonyosying P, Psaila B, Sola-Visner M, Cooper N, Hider R, Porter J. Vlachodimitropoulou E, et al. Blood. 2017 Oct 26;130(17):1923-1933. doi: 10.1182/blood-2016-10-740241. Epub 2017 Sep 1. Blood. 2017. PMID: 28864815 Free PMC article.

4

Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded mice.

Porter JB, Hoyes KP, Abeysinghe RD, Brooks PN, Huehns ER, Hider RC. Porter JB, et al. Among authors: hider rc. Blood. 1991 Nov 15;78(10):2727-34. Blood. 1991. PMID: 1824264 Free article.

5

Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice.

Porter JB, Morgan J, Hoyes KP, Burke LC, Huehns ER, Hider RC. Porter JB, et al. Among authors: hider rc. Blood. 1990 Dec 1;76(11):2389-96. Blood. 1990. PMID: 2257308 Free article.

6

Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.

Hershko C, Link G, Pinson A, Peter HH, Dobbin P, Hider RC. Hershko C, et al. Among authors: hider rc. Blood. 1991 May 1;77(9):2049-53. Blood. 1991. PMID: 2018841 Free article.

7

The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.

Hershko C, Theanacho EN, Spira DT, Peter HH, Dobbin P, Hider RC. Hershko C, et al. Among authors: hider rc. Blood. 1991 Feb 1;77(3):637-43. Blood. 1991. PMID: 1991172 Free article.

8

Biliary and urinary metabolic profiles of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in the rat.

Lu SL, Gosriwatana I, Liu DY, Liu ZD, Mallet AI, Hider RC. Lu SL, et al. Among authors: hider rc. Drug Metab Dispos. 2000 Aug;28(8):873-9. Drug Metab Dispos. 2000. PMID: 10901694

9

Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.

Zevin S, Link G, Grady RW, Hider RC, Peter HH, Hershko C. Zevin S, et al. Among authors: hider rc. Blood. 1992 Jan 1;79(1):248-53. Blood. 1992. PMID: 1728313 Free article.

10

The development of hydroxypyridin-4-ones as orally active iron chelators.

Hider RC, Singh S, Porter JB, Huehns ER. Hider RC, et al. Ann N Y Acad Sci. 1990;612:327-38. doi: 10.1111/j.1749-6632.1990.tb24320.x. Ann N Y Acad Sci. 1990. PMID: 2291561 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters